logo-loader

NA Proactive news snapshot: Empower Clinics, Codebase Ventures, EuroLife Brands, Enwave Corporation UPDATE …

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

Newspapers and laptop
Your daily round-up from the world of Proactive

Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF) told shareholders Thursday that its Sun Valley Health division completed the sale of its first franchise territory in Oklahoma. Under Sun Valley’s business model, a franchisee pays an upfront fee based on the territory location and population index in addition to a monthly recurring revenue-based royalty. The buyers are a pair of entrepreneurs with an extensive background of 20 years owning and operating a health and wellness centre, according to Empower.

Codebase Ventures Inc (CSE:CODE) (OTCMKTS:BKLLF) said it has formed a wholly-owned subsidiary named Titan Shrooms & Psychedelics Inc to spearhead its investments into the emerging market for mental health treatments using mushrooms and psychedelics. "Mushrooms and psychedelics fit our mandate as an emerging sector with tremendous potential for those suffering from certain mental health issues, as was well documented on 60 Minutes at the end of December," said Brian Keane, a director with Codebase Ventures. For most, psychedelic drugs conjure up images of the 1960's, hippies tripping out on LSD or magic mushrooms. However, the 60 Minutes program talks about how cancer patients with painful anxiety have found more peace after being given a drug that was once a symbol of the 60's counterculture.

EuroLife Brands Inc (CSE:EURO) (OTCMKTS:EURPF) told shareholders on Thursday that it has acquired the global rights to CBD food products in over 75 jurisdictions. The move bolsters the Toronto-based company’s portfolio of CBD products to include hot sauce, olive oils and other related foodstuffs. CEO Sean Moniz said that the company’s research showed a “significant market opportunity” throughout Europe for CBD-infused food products.

Enwave Corporation (CVE:ENW) (OTCMKTS:NWVXF) announced Thursday it has signed a royalty-bearing commercial license agreement with a Colombian snack maker. In a statement, Enwave said Pacifico Snacks SAS will use the company’s flagship Radiant Energy Vacuum (REV) technology to produce dried-fruit snacks for the North American grocery market. Under the terms of the license, Pacifico Snacks purchased a 10-kilowatt commercial REV machine to initiate commercial production. The REV machine/technology precisely dehydrates organic materials and has pharmaceutical uses as well.

CleanSpark Inc (OTCMKTS:CLSK), a designer of microgrid and distributed energy resource management systems, issued Thursday a clarification regarding its connections to the cannabis industry as it works to finalize its Nasdaq listing.  “CleanSpark would like to clarify that it has set an internal policy to not contract directly with any companies in the cannabis industry and that it has not in the past and will not in the future divert from this policy, absent fundamental changes in US cannabis laws,” the company said

Media Central Corporation (CSE:LFLYY), the owner of weekly Toronto-based newspaper NOW Magazine, said Thursday that it is boosting the paper’s editorial team with two new appointments. The company said the new senior editors will help to spearhead the paper’s growth and direction in 2020. Toronto-based Media Central acquired the alternative news and entertainment paper in November 2019.

Nextleaf Solutions Ltd (CSE:OILS) (OTCMKTS:OILFF) announced Thursday that Health Canada has granted its commercialization partner Nextleaf Labs Ltd a Research Licence under the Cannabis Act. The newly granted licence allows Nextleaf Labs to conduct a number of research and development activities, including stability trials on the company's nanoemulsified water-soluble THC and CBD formulations, according to a statement. The Research Licence is the second Health Canada licence granted to Nextleaf Labs, following a Standard Processing Licence granted in September 2019. 

InnoCan Pharma (CSE:INNO) announced that Peter Bloch, the CEO of medical device developer Bresotec Inc, has joined its board of directors. Prior to leading Bresotec, Bloch was CEO and chairman of Bionik Laboratories Corp (OTCMKTS:BNKL), a prosthetics company based in Toronto. He’s also held senior management roles at Sanofi-Aventis Canada, Intellivax International Inc., Gennum Corporation and Tribute Pharmaceuticals. Bloch replaces outgoing director Daryl Fridhandler, who resigned this week.

Kerr Mines Inc's (TSE:KER) (OTCMKTS:KERMF) plans for a restart of the past producing Copperstone gold mine in Arizona, USA have been boosted with the receipt of an approval for the firm's mining plan of operation (MPO). Yesterday (January 22) the US Bureau of Land Management (BLM) issued a decision of record (DOR) based on a 'finding of no significant impact (FONSI) , the company said in a statement. This final approval marks the conclusion of a permit modification effort that began in 2018, Kerr added.

Otso Gold Corp (CVE:OTSO) hit promising intercepts in its current drill campaign at its Finnish gold project. The Toronto-based firm is currently conducting an infill drill program to form a basis to restart production at the Otso gold project. The initial round of drill results increased the firm’s confidence in the mineralization at the project, Otso said in a release Thursday.

MGX Minerals Inc (CSE:XMG) (OTCMKTS:MGXMF) announced Thursday that the Supreme Court of British Columbia has confirmed that Jared Lazerson is CEO of the company. The court’s decision ends a months-long dispute between the company and two board members who attempted but failed to oust Lazerson during a meeting on October 7. The two board members, Lyndon Patrick and Michael Reimann, had tabled a motion to remove Lazerson while Lazerson and another director, Andris Kikauka, voted against it. Both directors then took their case to the high court but were ruled against on January 17.

CytoDyn Inc (OTCMKTS:CYDY) announced that CEO Nader Pourhassan will give a presentation during Wall Street Reporter’s “NEXT SUPER STOCK Live” conference on Thursday. The late-stage biotechnology company responsible for the versatile product candidate leronlimab will present a comprehensive overview of the Company’s clinical, regulatory and commercialization priorities at 12:30 pm ET (9:30 am PT) on January 23. The livestream event can be watched here.

Co-Diagnostics Inc (NASDAQ:CODX), a molecular diagnostics company, announced Thursday that it has completed the principle design work for a genetic screening test to detect the deadly Wuhan coronavirus. The test was developed using the Salt Lake City company’s PCR-based Co-Primer technology and proprietary software system while adhering to the guidelines laid out by the World Health Organization and the Centers for Disease Control. The pneumonia-like coronavirus was discovered in Wuhan, China on December 31, and at least 17 people have died, according to The New York Times.

AgraFlora Organics International Inc (CSE:AGRA) (OTCMKTS:AGFAF) revealed Thursday that Farmako GmbH, through its wholly-owned subsidiary Farmako Limited, has received its UK Home Office Controlled Drug License. AgraFlora completed the acquisition of The Good Company and its subsidiary European medical cannabis distributor Farmako GmbH, at the beginning of January.

Endeavour Mining Corporation (TSE:EDV)(OTCMKTS:EDVMF) is eyeing further growth in production and reduction in debt this year as the West Africa-focused gold miner posted results for the fourth quarter and year to end December. The firm achieved output guidance in 2019 for the seventh year in a row, at 651,000 ounces of gold (up 6% from 2018) at an all-in-sustaining cost (AISC) of US$813 per ounce.

Mota Ventures Corp (CSE:MOTA), previously known as Primary Energy Metals Inc (CSE:PRIM) (OTCMKTS:PEMTD) said Thursday that its subsidiary Ihuana S.A.S., has forged a research pact with La Fundacion Universitaria de Ciencias de la Salud (The University Foundation of Health Sciences) in Bogota, Colombia.  Ihuana and the University will cooperate in working on scientific investigations related to the medical use of cannabis products.

Capstone Turbine Corporation (NASDAQ:CPST) announced Thursday that a large automotive manufacturing facility in Mexico, which uses a fleet of the company’s clean-energy microturbines, has signed a new Factory Protection Plan (FPP) long-term service contract for 2 megawatts (MW). In a statement, the company said its microturbines were commissioned in April 2015 and are installed at the facility for electronic components and lighting systems. The systems will be used for peak shaving and power-generation only, at this time. The customer employs more than 3,000 people with six production plants. 

LiteLink Technologies Inc (CSE:LLT) (OTCMKTS:LLNKF) is breaking fresh ground with the unveiling of a full software-as-a-service (SaaS) subscription model for its popular 1SHIFT Logistics software platform. The Burnaby, British Columbia company’s 1 SHIFT Logistics is a software platform that enables brokers, shippers and carriers to track shipments and settle payments in real-time without having to micromanage drivers.

RNC Minerals Corp (TSE:RNX), the west Australia-focused gold miner, expects group output of between 90,000 and 95,000 ounces for 2020, at an average all-in-sustaining-cost of US$1,050 to US$1,200 per ounce as it continues to ramp up production and lower costs. The firm highlighted though that its guidance does not include the contribution from high-grade coarse gold at its Beta Hunt mine in Australia. 

PreveCeutical Medical Inc (CSE:PREV) (OTCMKTS:PRVCF), the health sciences company developing preventative therapies, is moving one step forward to securing its intellectual property with the retention of a patent law firm. The Vancouver-based company has hired Australian legal experts Griffith Hack as its patent attorneys to protect its intellectual property and help obtain the necessary patents associated with its therapeutic research and development. “Following the successful completion of our novel designed peptides derived from Caribbean blue scorpion venom and with our two other programs coming to a close during 2020, we will need to ensure all our intellectual property is patented in order to protect its value,” PreveCeutical said in a statement.

Surge Holdings Inc (OTCMKTS:SURG) is bringing on sales expert Tod Farnan to help the Tennessee-based company in its goal of onboarding over 100,000 retail stores to the SurgePays Marketplace Network. Farnan, who is taking the role of national sales director for SurgePays, built his sales career at Bank of America Merchant Services and helped developed a credit card application division with Target, K-Mart and Menards. “We are pleased to welcome Tod to the senior management team,” said Brian Cox, CEO at Surge Holdings. “Tod brings industry knowledge working with convenience stores as well as growing national sales organizations, which will be invaluable as we rapidly expand our SurgePays Marketplace Network.”

American Manganese Inc. (OTCMKTS:AMY) announced its attendance at Fully Charged LIVE from February 1-2, 2020 at the Circuit of the Americas in Austin, Texas. Fully Charged LIVE is bringing together over 50 Electrified Vehicles on-site and over 50 exhibitors of Clean Energy and Electric Vehicle related technologies. The event will be attended by Larry Reaugh and Zarko Meseldzija at booth number 304.

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP), a biopharmaceutical company, will be presenting pre-clinical results for TNX-801, its smallpox vaccine, in a poster presentation at this year’s ASM Biothreats Conference in Arlington, Virginia, which takes place from January 28 to January 30. The title of the Tonix talk, which will be delivered by CEO Dr. Seth Lederman,  is Synthetic Chimeric Horsepox Virus (scHPXV) from Monkeypox. It will be presented on January 29 from 4:15pm to 5:15pm at the Hyatt Regency Crystal City, which is located on the grounds of Reagan National Airport. Tonix is a clinical-stage biopharmaceutical company focused on discovering and developing small molecules and biologics to treat pain and addiction conditions. Tonix’s lead product candidate is TNX-102SL*, which is being developed for the treatment of posttraumatic stress disorder, fibromyalgia, agitation in Alzheimer’s disease and alcohol use disorder

Carube Copper Corp (CVE:CUC) said late on Wednesday that the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement, announced on December 3, 2019, which will see the issue of 50.1 million shares at a price of 5 cents each with 38 placees.

Silvercorp Metals Inc (NYSEAMERICAN:SVM) (TSX:SVM) will release its unaudited financial and operating results for the third quarter ended December 31 on February 6 after market close.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of AgraFlora Organics International Inc. named herein, including the promotion by the Company of AgraFlora Organics International Inc. in any...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Genprex sees newly licensed diabetes gene therapy as an...

Genprex Inc (NASDAQ:GNPX) CEO Rodney Varner tells Proactive the Texas-based biotech has signed a licensing agreement with the University of Pittsburgh for a diabetes gene therapy that could have the potential to treat Type 1 and Type 2 diabetes. Varner says the newly licensed diabetes gene...

2 days, 14 hours ago

10 min read